Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
Oriana Miltiadous, Ming Hou, James B. Bussel
Blood (2019) Vol. 135, Iss. 7, pp. 472-490
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

How we treat primary immune thrombocytopenia in adults
Xinguang Liu, Yu Hou, Ming Hou
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 54
Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells
Karolin Trautmann‐Grill, Malte von Bonin, Anett Georgi, et al.
The Lancet (2025) Vol. 405, Iss. 10472, pp. 25-28
Closed Access | Times Cited: 4
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
Philipp von Hundelshausen, Reinhard Lorenz, Wolfgang Siess, et al.
Thrombosis and Haemostasis (2021) Vol. 121, Iss. 11, pp. 1395-1399
Open Access | Times Cited: 77
Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease
Philipp von Hundelshausen, Wolfgang Siess
Cancers (2021) Vol. 13, Iss. 5, pp. 1103-1103
Open Access | Times Cited: 64
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives
Nicola Vianelli, Giuseppe Auteri, Francesco Buccisano, et al.
Annals of Hematology (2022) Vol. 101, Iss. 5, pp. 963-978
Open Access | Times Cited: 43
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
Yunfei Chen, Yanmei Xu, Ying Chi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice
Fei Song, Hanny Al‐Samkari
Journal of Blood Medicine (2021) Vol. Volume 12, pp. 653-664
Open Access | Times Cited: 44
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
Lu Sun, Juan Wang, Linlin Shao, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 4, pp. e289-e298
Closed Access | Times Cited: 43
Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression
June Li, Danielle Karakas, Feng Xue, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 16
Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia
Alessandro Allegra, Nicola Cicero, Giuseppe Mirabile, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4438-4438
Open Access | Times Cited: 15
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink
Tomás José González‐López, Drew Provan, Abelardo Bárez, et al.
Blood Reviews (2023) Vol. 61, pp. 101112-101112
Closed Access | Times Cited: 14
Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia
Panpan Han, Tianshu Yu, Yu Hou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
Yue Lv, Huiping Shi, Hong Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
The Challenge for a Correct Diagnosis of Refractory Thrombocytopenia: ITP or MDS with Isolated Thrombocytopenia?
Aikaterini Kosmidou, Eleni Gavriilaki, Athanasios Tragiannidis
Cancers (2024) Vol. 16, Iss. 8, pp. 1462-1462
Open Access | Times Cited: 4
Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia – Case Report
Ibrahim Zoubi, Amir Warwar, Shoshan Perek, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 1-5
Open Access
Eltrombopag for the treatment of refractory connective tissue disease-related thrombocytopenia: a pilot study of 52 cases
Siying Deng, Bei Wang, Ziwei Hu, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
The efficacy of hydroxychloroquine in paediatric chronic immune thrombocytopenia: A retrospective cohort study
Jing Liu, Yuelun Zhang, Hongmei Song, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Refractory immune thrombocytopenia treated with low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag: Two case reports
Yu‐Xia Jiang, Yani Xu, Haiying Wu, et al.
Medicine (2025) Vol. 104, Iss. 6, pp. e41449-e41449
Open Access
Effect of nursing risk management on treatment compliance and family psychological status in pediatric patients with idiopathic thrombocytopenic purpura
Dan Chen, Wei Zhang
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1049-1056
Closed Access
Plasma Exosomes Derived from Patients with Primary Immune Thrombocytopenia Attenuate TBX21+ Regulatory T Cell-Mediated Immune Suppression via MiR-363-3p
Yuan‐Lan Huang, Peng Liu, Ying Xu, et al.
Inflammation (2025)
Open Access
Immune thrombocytopenia in adolescents and young adults
Alexandra Schifferli
Frontiers in Medicine (2025) Vol. 12
Open Access
Refractory autoimmune cytopenia in children, possible role for sirolimus treatment
Marwa Abd Elhady, Samar Hasan Abd El Fadeel, Nermeen Galal, et al.
Egyptian Pediatric Association Gazette (2025) Vol. 73, Iss. 1
Open Access
Thrombocytopenia
Alice Cusick
Oxford University Press eBooks (2025), pp. 407-414
Closed Access
Refractory immune thrombocytopenia in adults: Towards a new definition
Donald M. Arnold, Bianca Clerici, Ekaterina Ilicheva, et al.
British Journal of Haematology (2023) Vol. 203, Iss. 1, pp. 23-27
Open Access | Times Cited: 10
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience
Étienne Crickx, Mikaël Ebbo, Étienne Rivière, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 4, pp. 883-889
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top